cas 160052-43-7|| where to buy [3-[tert-butyl(diphenyl)silyl]oxy-2,2-difluoro-propyl] trifluoromethanesulfonate

Produktname:[3-[tert-butyl(diphenyl)silyl]oxy-2,2-difluoro-propyl] trifluoromethanesulfonate

IUPAC Name:3-[(tert-butyldiphenylsilyl)oxy]-2,2-difluoropropyl trifluoromethanesulfonate

: CAS：160052-43-7; Molekulare Formel：C20H23F5O4SSi; Reinheit：95%

Packungseinheit	Verfügbarer Vorrat	Preis($)
CM1076223-100mg	in stock	ǸŤħ
CM1076223-250mg	in stock	ƚƚǸ
CM1076223-500mg	in stock	ŌǙƈ
CM1076223-1g	in stock	ƈħŮ
CM1076223-5g	in stock	ǸǪǸƚ
CM1076223-10g	in stock	ŌħǪǸ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 160052-43-7 regularly via the above email.

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:160052-43-7; Molekulare Formel:C20H23F5O4SSi; Schmelzpunkt:-; SMILES-Code:CC(C)(C)[Si](OCC(F)(F)COS(=O)(=O)C(F)(F)F)(C1=CC=CC=C1)C1=CC=CC=C1; Dichte:

: Katalognummer:CM1076223; Molekulargewicht:482.54; Siedepunkt:; Mdl-Nr.:; Lagerung:

: Fluorinated Compounds; Fluorine is the most electronegative element in the periodic table, and the fluorine atom has a small atomic radius, so fluorine-containing organic compounds have many wonderful properties. For example, the introduction of fluorine atoms or fluorine-containing groups into drug molecules can improve the permeability to cell membranes, metabolic stability and bioavailability; in addition, the introduction of fluorine atoms will improve the lipid solubility of the compound and promote its absorption in the body. The speed of delivery changes the physiological effect. In the field of medicinal chemistry, the introduction of fluorine atoms into organic molecules is an important direction for the development of new anticancer drugs, antitumor drugs, antiviral agents, anti-inflammatory drugs, and central nervous system drugs.